UK regulators will be able to start the first-ever clinical trial to gain more information on dimethyltryptamine (DMT) in treating various mental health disorders, such as depression. According to The Guardian, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the trial early this week. However, the company, Small Pharma, that will run the trial alongside the Imperial College is still in talks with the Home Office in order to be granted government permission. Continue reading UK to Start a Trial on Psychedelic drug DMT to Treat Depression at Canex.
Excerpt only …
READ MORE BELOW
Source : UK to Start a Trial on Psychedelic drug DMT to Treat Depression
reposted by Cannabis News World